Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection

被引：0

作者：

Asmaa Hachim

Niloufar Kavian

Carolyn A. Cohen

Alex W. H. Chin

Daniel K. W. Chu

Chris K. P. Mok

Owen T. Y. Tsang

Yiu Cheong Yeung

Ranawaka A. P. M. Perera

Leo L. M. Poon

J. S. Malik Peiris

Sophie A. Valkenburg

机构：

[1] The University of Hong Kong,HKU

[2] Sorbonne Paris Cité,Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine

[3] Assistance Publique–Hôpitaux de Paris,Faculté de Médecine Université Paris Descartes

[4] Hôpital Universitaire Paris Centre,Institut Cochin

[5] Centre Hospitalier Universitaire Cochin,Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine

[6] Service d’Immunologie Biologique,Infectious Diseases Centre

[7] INSERM U1016,undefined

[8] Université Paris Descartes,undefined

[9] Sorbonne Paris Cité,undefined

[10] The University of Hong Kong,undefined

[11] Princess Margaret Hospital,undefined

[12] Hospital Authority of Hong Kong,undefined

来源：

Nature Immunology | 2020年 / 21卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

引用

页码：1302 / 1302

共 50 条

[21] Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein
Wang, Xiaohui
Lam, Joy-Yan
Wong, Wan-Man
Yuen, Chun-Kit
Cai, Jian-Piao
Au, Shannon Wing-Ngor
Chan, Jasper Fuk-Woo
To, Kelvin K. W.
Kok, Kin-Hang
Yuen, Kwok-Yung
MBIO, 2020, 11 (05): : 1 - 13
[22] Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications
Valcarcel, Antonio
Bensussen, Antonio
Alvarez-Buylla, Elena R.
Diaz, Jose
FRONTIERS IN GENETICS, 2021, 12
[23] SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer
Matsuoka, Kazuhiro
Imahashi, Nobuhiko
Ohno, Miki
Ode, Hirotaka
Nakata, Yoshihiro
Kubota, Mai
Sugimoto, Atsuko
Imahashi, Mayumi
Yokomaku, Yoshiyuki
Iwatani, Yasumasa
JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (03)
[24] SARS-CoV-2 ORF8 modulates lung inflammation and clinical disease progression
Mcgrath, Marisa E.
Xue, Yong
Taylor, Louis
Dillen, Carly
Ardanuy, Jeremy
Gonzalez-Juarbe, Norberto
Baracco, Lauren
Kim, Raymond
Hart, Rebecca
Assad-Garcia, Nacyra
Vashee, Sanjay
Frieman, Matthew B.
PLOS PATHOGENS, 2024, 20 (05)
[25] SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin
Pereira, Filipe
GENE, 2021, 784
[26] An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
Hassan, Sk Sarif
Kodakandla, Vaishnavi
Redwan, Elrashdy M.
Lundstrom, Kenneth
Choudhury, Pabitra Pal
Abd El-Aziz, Tarek Mohamed
Takayama, Kazuo
Kandimalla, Ramesh
Lal, Amos
Serrano-Aroca, Angel
Azad, Gajendra Kumar
Aljabali, Alaa A. A.
Palu, Giorgio
Chauhan, Gaurav
Adadi, Parise
Tambuwala, Murtaza
Brufsky, Adam M.
Baetas-da-Cruz, Wagner
Barh, Debmalya
Azevedo, Vasco
Bazan, Nikolas G.
Andrade, Bruno Silva
Silva, Raner Jose Santana
Uversky, Vladimir N.
PEERJ, 2022, 10
[27] Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein
Flower, Thomas G.
Buffalo, Cosmo Z.
Hooy, Richard M.
Allaire, Marc
Ren, Xuefeng
Hurley, James H.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (02)
[28] SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR
Laprise, Frederique
Arduini, Ariana
Duguay, Mathew
Pan, Qinghua
Liang, Chen
VIRUSES-BASEL, 2024, 16 (07):
[29] The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Li, Jin-Yan
Liao, Ce-Heng
Wang, Qiong
Tan, Yong-Jun
Luo, Rui
Qiu, Ye
Ge, Xing-Yi
VIRUS RESEARCH, 2020, 286
[30] Detection of SARS-CoV-2 Δ426 ORF8 Deletion Mutant Cluster in NGS Screening
Cecchetto, Riccardo
Tonon, Emil
Medaina, Nicoletta
Turri, Giona
Diani, Erica
Piccaluga, Pier Paolo
Salomoni, Angela
Conti, Michela
Tacconelli, Evelina
Lagni, Anna
Lotti, Virginia
Favarato, Mose
Gibellini, Davide
MICROORGANISMS, 2023, 11 (10)

← 1 2 3 4 5 →